Alembic Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
Reserves | 5,155.43 | 4,869.60 | 4,374.99 | 5,251.03 | 5,062.50 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 5,194.74 | 4,908.91 | 4,414.30 | 5,290.34 | 5,101.81 |
Secured Loans | 102.22 | 100.04 | 165.07 | 0.00 | 0.02 |
Unsecured Loans | 1,091.71 | 391.95 | 544.86 | 706.12 | 583.59 |
Total Debt | 1,193.93 | 491.99 | 709.93 | 706.12 | 583.61 |
Other Liabilities | 124.31 | 109.51 | 106.20 | 95.82 | 85.52 |
Total Liabilities | 6,512.98 | 5,510.41 | 5,230.43 | 6,092.28 | 5,770.94 |
APPLICATION OF FUNDS : | |||||
Gross Block | 4,100.64 | 3,859.15 | 3,441.27 | 2,733.10 | 2,452.31 |
Less: Accumulated Depreciation | 1,587.17 | 1,323.49 | 1,063.82 | 962.00 | 678.49 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 2,513.47 | 2,535.66 | 2,377.45 | 1,771.10 | 1,773.82 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 837.23 | 524.36 | 601.28 | 2,304.23 | 2,182.53 |
Investments | 259.56 | 226.68 | 229.27 | 219.36 | 343.09 |
Current Assets, Loans & Advances | |||||
Inventories | 1,976.34 | 1,353.07 | 1,275.13 | 1,396.83 | 1,341.96 |
Sundry Debtors | 1,480.67 | 1,340.12 | 1,201.20 | 988.33 | 421.86 |
Cash and Bank Balance | 20.85 | 26.49 | 28.46 | 21.90 | 61.44 |
Loans and Advances | 288.34 | 268.88 | 275.43 | 337.41 | 482.37 |
Total Current Assets | 3,766.20 | 2,988.56 | 2,780.22 | 2,744.47 | 2,307.63 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 940.53 | 823.26 | 830.03 | 871.72 | 772.70 |
Provisions | 102.76 | 64.88 | 69.96 | 63.64 | 53.71 |
Total CL & Provisions | 1,043.29 | 888.14 | 899.99 | 935.36 | 826.41 |
Net Current Assets | 2,722.91 | 2,100.42 | 1,880.23 | 1,809.11 | 1,481.22 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 215.74 | 210.11 | 161.30 | 151.29 | 142.80 |
Deferred Tax Liability | 138.32 | 131.28 | 83.14 | 197.69 | 188.92 |
Net Deferred Tax | 77.42 | 78.83 | 78.16 | -46.40 | -46.12 |
Other Assets | 102.39 | 44.46 | 64.04 | 34.88 | 36.40 |
Total Assets | 6,512.98 | 5,510.41 | 5,230.43 | 6,092.28 | 5,770.94 |
Contingent Liabilities | 120.25 | 65.03 | 117.45 | 62.87 | 100.46 |